Harnessing the Power of Exosomes
From Exosomes to Insight
Rivela Diagnostics envisions a world in which a simple blood test is sufficient to allow Multi Cancer Early Detection, discovering cancer at the earliest detectable moment, enabling enhanced, personalised patient treatments and outcomes. By achieving this goal, we will reduce the devastating impact of the rise of global cancer rates and improve the lives of those affected by the disease.
HansaBioMed LS (HBM) is the oldest exosome focused company, established in EU back in 2007, and still the only EV/Exosomes focused Life Sciences company. HBM sells globally the largest variety of products in the field including EV standards, products for EV isolation and characterization, specific kits and Abs. HBM also provides a wide variety of services in the field including partnering for early R&D projects and pilot studies.